Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma

The fibroblast growth factor (FGF) signaling cascade is one of the key signaling pathways in hepatocellular carcinoma (HCC). FGF has been shown to augment vascular endothelial growth factor (VEGF)-mediated HCC development and angiogenesis, as well as to potentially lead to resistance to VEGF/VEGF re...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Mol Sci
Huvudupphovsmän: Le, Thi Bich Uyen, Vu, Thanh Chung, Ho, Rebecca Zhi Wen, Prawira, Aldo, Wang, Lingzhi, Goh, Boon Cher, Huynh, Hung
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7764786/
https://ncbi.nlm.nih.gov/pubmed/33321903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21249405
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk